Protagonist Therapeutics, Inc Business Finance Contracts & Agreements

30 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Protagonist Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Protagonist Therapeutics, Inc
Biotechnology
2025
Description of Protagonist Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Protagonist Therapeutics, Inc
Biotechnology
2024
Underwriting Agreement between Protagonist Therapeutics, Inc. and J.P. Morgan Securities LLC, Jefferies LLC, and Piper Sandler & Co. (April 2023)
Underwriting Agreements
Protagonist Therapeutics, Inc
Biotechnology
NY
2023
Description of Protagonist Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Protagonist Therapeutics, Inc
Biotechnology
2023
Description of Protagonist Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Stock Agreements
Protagonist Therapeutics, Inc
Biotechnology
2022
Underwriting Agreement between Protagonist Therapeutics, Inc. and J.P. Morgan Securities LLC, Jefferies LLC, and Piper Sandler & Co. (June 15, 2021)
Underwriting Agreements
Protagonist Therapeutics, Inc
Biotechnology
NY
2021
Description of Protagonist Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Stock Agreements
Protagonist Therapeutics, Inc
Biotechnology
2021
Underwriting Agreement between Protagonist Therapeutics, Inc. and J.P. Morgan Securities LLC, SVB Leerink LLC, and Piper Sandler & Co. (December 2020)
Underwriting Agreements
Protagonist Therapeutics, Inc
Biotechnology
NY
2020
Underwriting Agreement between Protagonist Therapeutics, Inc. and Jefferies LLC, BMO Capital Markets Corp. (May 2020)
Underwriting Agreements
Protagonist Therapeutics, Inc
Biotechnology
NY
2020
Description of Protagonist Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Stock Agreements
Protagonist Therapeutics, Inc
Biotechnology
2020
Open Market Sale Agreement between Protagonist Therapeutics, Inc. and Jefferies LLC (November 27, 2019)
Equity Distribution Agreements
Protagonist Therapeutics, Inc
Biotechnology
NY
2019
Protagonist Therapeutics, Inc. Registration Rights Agreement with Purchasers (August 2018)
Registration Rights Agreements
Protagonist Therapeutics, Inc
Biotechnology
DE
2018
Underwriting Agreement between Protagonist Therapeutics, Inc. and Underwriters (Leerink Partners LLC, Barclays Capital Inc.) for 3,530,000 Shares of Common Stock
Underwriting Agreements
Protagonist Therapeutics, Inc
Biotechnology
DE
2017
Modification and Assumption of Collaboration Program Agreement between Protagonist Therapeutics Inc. and Zealand Pharma A/S
Modification Agreements
Protagonist Therapeutics, Inc
Biotechnology
2016
Patent Assignment Agreement between Zealand Pharma A/S and Protagonist Therapeutics, Inc.
Assignment Agreements
Protagonist Therapeutics, Inc
Biotechnology
NY
2016
Protagonist Therapeutics, Inc. Third Amended and Restated Investor Rights Agreement (July 31, 2016)
Investor Rights Agreements
Protagonist Therapeutics, Inc
Biotechnology
DE
2016
Common Stock Certificate of Protagonist Therapeutics, Inc.
Stock Agreements
Protagonist Therapeutics, Inc
Biotechnology
2016
Underwriting Agreement between Protagonist Therapeutics, Inc. and Underwriters (Leerink Partners LLC, Barclays Capital Inc.)
Underwriting Agreements
Protagonist Therapeutics, Inc
Biotechnology
DE
2016
Right of First Negotiation Agreement between Johnson & Johnson Development Corporation and Protagonist Therapeutics, Inc.
Investor Rights Agreements
Protagonist Therapeutics, Inc
Biotechnology
2016
Modification and Assumption of Collaboration Program Agreement between Protagonist Therapeutics Inc. and Zealand Pharma A/S
Modification Agreements
Protagonist Therapeutics, Inc
Biotechnology
2016
Patent Assignment Agreement between Zealand Pharma A/S and Protagonist Therapeutics, Inc.
Assignment Agreements
Protagonist Therapeutics, Inc
Biotechnology
NY
2016
Second Amended and Restated Investor Rights Agreement between Protagonist Therapeutics, Inc. and Preferred Stockholders (July 10, 2015)
Investor Rights Agreements
Protagonist Therapeutics, Inc
Biotechnology
DE
2016
Protagonist Therapeutics, Inc. Pre-Funded Warrant to Purchase Common Stock
Warrant Agreements
Protagonist Therapeutics, Inc
Biotechnology
NY
2023
Protagonist Therapeutics and Stockholders Section 3(a)(9) Exchange Agreement (December 2018)
Exchange Agreements
Protagonist Therapeutics, Inc
Biotechnology
2018
Protagonist Therapeutics, Inc. Warrant to Purchase Common Stock Agreement
Warrant Agreements
Protagonist Therapeutics, Inc
Biotechnology
NY
2018
Class B Common Stock Purchase Warrant Agreement between Protagonist Therapeutics, Inc. and Holder
Warrant Agreements
Protagonist Therapeutics, Inc
Biotechnology
2018
Class A Common Stock Purchase Warrant Agreement between Protagonist Therapeutics, Inc. and Holder
Warrant Agreements
Protagonist Therapeutics, Inc
Biotechnology
2018
Protagonist Therapeutics, Inc. 2016 Employee Stock Purchase Plan
Stock Agreements
Protagonist Therapeutics, Inc
Biotechnology
2016
Protagonist Therapeutics, Inc. 2016 Equity Incentive Plan
Equity Distribution Agreements
Protagonist Therapeutics, Inc
Biotechnology
DE
2016
Protagonist Therapeutics, Inc. 2007 Stock Option and Incentive Plan (As Amended and Restated)
Stock Agreements
Protagonist Therapeutics, Inc
Biotechnology
DE
2016